Cargando…

Retinal vein occlusion in COVID-19: A novel entity

Coronavirus disease 2019 (COVID-19) is a form of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that has been declared a pandemic by the World Health Organization (WHO). Ocular manifestations related to COVID-19 are uncommon with conjunctivitis being reported in a few cases. We report...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sheth, Jay Umed, Narayanan, Raja, Goyal, Jay, Goyal, Vinod
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2020
Materias:	Case Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7727974/ https://www.ncbi.nlm.nih.gov/pubmed/32971697 http://dx.doi.org/10.4103/ijo.IJO_2380_20

Ejemplares similares

Response to comments on: Retinal vein occlusion in COVID-19: A novel entity
por: Sheth, Jay U, et al.
Publicado: (2021)

Response to comments on: Retinal vein occlusion in COVID 19: A novel entity
por: Sheth, Jay U, et al.
Publicado: (2021)

Comments on: Retinal vein occlusion in COVID-19: A novel entity
por: Reddy, P Raja Rami, et al.
Publicado: (2021)

Comments on: Retinal vein occlusion in COVID-19: A novel entity
por: Mahendradas, Padmamalini, et al.
Publicado: (2021)

Bilateral Central Retinal Vein Occlusion as Presenting Feature of Chronic Myeloid Leukemia
por: Narang, Subina, et al.
Publicado: (2016)

Toxic Posterior Segment Syndrome Presenting as Occlusive Retinal Vasculitis following Vitreoretinal Surgery
por: Sahoo, Niroj Kumar, et al.
Publicado: (2021)

Management of Submacular Hemorrhage Using Intravitreal Brolucizumab with Pneumatic Displacement: A Case Series
por: Chakraborty, Somnath, et al.
Publicado: (2022)

Contralateral Effect following Intravitreal Brolucizumab Injection in Diabetic Macular Edema
por: Chakraborty, Somnath, et al.
Publicado: (2022)

Intravitreal Brolucizumab for Choroidal Neovascularization Associated to Angioid Streaks
por: Chakraborty, Somnath, et al.
Publicado: (2022)

Response of extra-large pigment epithelial detachment to intravitreal brolucizumab injection
por: Chakraborty, Somnath, et al.
Publicado: (2023)

Neurodegeneration in branch retinal vein occlusion
por: Alshareef, Rayan A., et al.
Publicado: (2016)

Hemi-retinal vein occlusion in a young patient with COVID-19
por: Finn, Avni P., et al.
Publicado: (2021)

Central retinal vein occlusion with COVID-19 infection as the presumptive etiology
por: Walinjkar, Jaydeep A, et al.
Publicado: (2020)

Partial Central Retinal Artery Occlusion: An Underrecognized Entity
por: Carranza-Casas, Mario, et al.
Publicado: (2020)

One-year outcomes of ziv-aflibercept for macular edema in central retinal vein occlusion
por: Eldeeb, Mohab, et al.
Publicado: (2017)

Retinal artery and vein occlusion in calciphylaxis
por: Naranjo, Andrea, et al.
Publicado: (2022)

Clinical Trials in Branch Retinal Vein Occlusion
por: Panakanti, Tandava Krishnan, et al.
Publicado: (2016)

Central retinal vein occlusion and occlusive vasculopathy at macula in a patient with recent COVID-19 infection
por: Kılıçarslan, Oğuzhan, et al.
Publicado: (2022)

Unilateral buried optic nerve head drusen triggering central retinal vein occlusion in young – Discovering an eclipsed entity
por: Vallinayagam, Muthu Krishnan, et al.
Publicado: (2022)

Central retinal vein occlusion post-COVID-19 vaccination
por: Sonawane, Nikita J, et al.
Publicado: (2022)

Impact of COVID-19 Pandemic on Retinopathy of Prematurity Services in the Indian Public Healthcare System
por: Chakraborty, Somnath, et al.
Publicado: (2023)

COVID-19-associated central retinal vein occlusion treated with oral aspirin
por: Venkatesh, Ramesh, et al.
Publicado: (2021)

Central Retinal Vein Occlusion after mRNA COVID-19 Vaccination
por: Ishiguro, Kiyona, et al.
Publicado: (2023)

Xanthogranulomatous pyelonephritis: A rare entity
por: Goyal, Subhash, et al.
Publicado: (2011)

Comorbidities in combined retinal artery and vein occlusions
por: Schmidt, Dieter
Publicado: (2013)

Acute retinal vein occlusion and cystic fibrosis
por: Starr, Matthew R., et al.
Publicado: (2018)

Elasomeran: Retinal-vein-occlusion: case report
Publicado: (2022)

Branch Retinal Vein Occlusion after Messenger RNA-Based COVID-19 Vaccine
por: Sugihara, Kazunobu, et al.
Publicado: (2022)

Concurrent central retinal artery occlusion and branch retinal vein occlusion in giant cell arteritis
por: Chu, Edward R, et al.
Publicado: (2010)

Neovascular Glaucoma Due to Branch Retinal Vein Occlusion Combined with Branch Retinal Artery Occlusion
por: An, Tae-Su, et al.
Publicado: (2013)

Hemi-central retinal vein occlusion as a rare manifestation of the hypercoagulable state in COVID-19
por: Russe-Russe, Jose R, et al.
Publicado: (2021)

Bilateral Simultaneous Central Retinal Vein Occlusion Secondary to COVID-19: A Case Report
por: Lin, Chien-Hung, et al.
Publicado: (2023)

Intravitreal ziv-aflibercept for macular edema following retinal vein occlusion
por: Paulose, Remya, et al.
Publicado: (2016)

COVID-19-Vaccine-Pfizer-BioNTech: Central retinal vein occlusion: case report
Publicado: (2022)

Branch retinal vein occlusion associated with quetiapine fumarate
por: Yong, Ku Chui, et al.
Publicado: (2011)

Central Retinal Vein Occlusion with Therapeutic Level of Anticoagulation
por: Salim, Sarwat, et al.
Publicado: (2009)

Presentation of acute central retinal vein occlusion in scleroderma
por: Malik, Faisal, et al.
Publicado: (2015)

Central retinal vein occlusion concomitant with dengue fever
por: Velaitham, Punithamalar, et al.
Publicado: (2016)

Tozinameran: Central retinal vein occlusion: case report
Publicado: (2022)

Bilateral Retinal Vein Occlusion-Simulated Coats’ Disease
por: Hua, Rui, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_urficok8bv33a5tjqju2l4d5d0